Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-20

FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approves the fixed-dose combination of chlordiazepoxide hydrochloride and clidinium bromide under an original application for Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlordiazepoxide hydrochloride and clidinium bromide (Chlordiazepoxide hydrochloride and clidinium bromide)

Snippet

ORIG AP for CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE (CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE)